COMMUNIQUÉS West-GlobeNewswire

National Stem Cell Foundation Joins with Axiom Space and the Saudi Space Agency to Expand Study of Neurodegenerative Disease in Microgravity
14/10/2026
Mission will investigate whether genetic ancestry and population-specific differences influence responses to therapies for Parkinson's disease, Primary Progressive Multiple Sclerosis, and Alzheimer’s disease The [...]
BayCare Proton Center Opens
14/10/2026
TAMPA, Fla., Oct. 14, 2026 (GLOBE NEWSWIRE) -- The BayCare Proton Center is now open and accepting patients, expanding access in the Tampa Bay area to one of the most advanced forms of radiation treatment for adults and [...]
A Pie in the Face for a Purpose: Legend Senior Living’s CEO, COO, and CFO Get Pied to Support the Alzheimer’s Association
14/10/2026
WICHITA, Kan., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Legend Senior Living’s CEO, COO, and CFO took pies in the face to help raise money for the Alzheimer’s Association. They were among six leaders who took part in the [...]
Siren Biotechnology Appoints Former FDA CBER Oncology Branch Chief to Clinical and Scientific Advisory Board
14/10/2026
Veteran oncology regulator brings more than 25 years of FDA experience as Siren advances SRN-101 into clinical development SAN FRANCISCO, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Siren Biotechnology, a clinical-stage [...]
Nova Leap Health Corp. to Highlight Record Performance at Planet MicroCap Showcase Toronto
14/10/2026
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Oct. 14, 2026 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a [...]
Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences
14/10/2026
Lyon (France), October 14, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will present and participate in meetings with institutional [...]
Valneva présentera ses activités et rencontrera les investisseurs lors de prochaines conférences santé aux États-Unis et en Europe
14/10/2026
Lyon (France), le 14 octobre 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui que des membres de son équipe dirigeante feront des présentations et [...]
Leo International Precision Health AG: Mr Leo Wang, Disposal
14/10/2026
Leo International Precision Health AG: Mr Leo Wang, Disposal Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them, 14. Oct 2026 [...]
Leo International Precision Health AG: Mr. Leo Wang, Disposal
14/10/2026
Leo International Precision Health AG: Mr. Leo Wang, Disposal Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them, 14. Oct 2026 [...]
Elevar Therapeutics Resubmits New Drug Application to FDA for Combination of Camrelizumab plus Rivoceranib for Use as a First-line Treatment Option for Unresectable or Metastatic Hepatocellular Carcinoma
14/10/2026
Combination achieved mOS of 23.8 months in patients with unresectable or metastatic HCC FORT LEE, N.J., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and a [...]
New York City Biotech Startups Neion Bio and Barnwell Bio Partner to Advance Biomanufacturing and Biosecurity
14/10/2026
The collaboration brings together Neion Bio's egg-based biologics manufacturing platform and Barnwell Bio's metagenomic biosurveillance capabilities, while highlighting the growing New York City life sciences ecosystem [...]
Baylor Genetics Study Finds Genome Sequencing Identifies Genetic Diagnoses in Nearly One-Third of Children with Intellectual Disability and Developmental Delay
14/10/2026
HOUSTON, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Baylor Genetics , a leading diagnostic genomics partner offering a full spectrum of comprehensive genetic tests and diagnostic services, today announced the publication of its [...]
UPDATE – MindBio Completes Manufacture of Next-Generation Voice AI Intoxication Detection Kiosk. Advances Software Validation & Testing In Preparation for First Commercial Pilot.
14/10/2026
VANCOUVER, British Columbia, Oct. 14, 2026 (GLOBE NEWSWIRE) -- MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) (the “ Company ” or “ MindBio ”), a biotechnology company advancing the [...]
NeOnc Strengthens Boardroom Firepower as Abu Dhabi Opens a New Path for Brain Cancer Drug Development
14/10/2026
DENVER, Oct. 14, 2026 (GLOBE NEWSWIRE) -- ( 247marketnews.com ) -- NeOnc Technologies Holdings (NASDAQ:NTHI) is strengthening its boardroom, while its clinical-development progress seeks to advance treatments for some [...]
What’s More Space Age Than Spider Silk Spun by Kraig Labs’ Transgenic Silkworms?
14/10/2026
DENVER, Oct. 14, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) — Kraig Biocraft Laboratories (OTCQB: KBLB) shipped its first commercial spider silk yarn order, while its production operation set new records, and its [...]
Tris Pharma Earns 2026 Great Place To Work Certification™
14/10/2026
MONMOUTH JUNCTION, N.J., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Tris Pharma, Inc. is proud to be Certified™ by Great Place To Work®. The prestigious award is based entirely on what current employees say about their [...]
MindBio Completes Manufacture of Next-Generation Voice AI Intoxication Detection Kiosk. Advances Software Validation & Testing Towards In Preparation for First Commercial Pilot.
14/10/2026
VANCOUVER, British Columbia, Oct. 14, 2026 (GLOBE NEWSWIRE) -- MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) (the “ Company ” or “ MindBio ”), a biotechnology company advancing the [...]
Oncolytics Biotech® Provides Update on GOBLET Study Clinical Data and Final PanCAN Grant Payment
14/10/2026
Completion of enrollment earlier this year and expected final PanCAN grant payment this quarter mark successful completion of a key phase of Cohort 5 Final Cohort 4 results expected in Q4 2026; initial Cohort 5 results [...]
Three-Year Real-World Study Compares Burosumab Treatment with Oral Phosphate and Active Vitamin D in Adults with XLH
14/10/2026
Publication in the Journal of Bone and Mineral Research offers new insight into the long-term XLH treatment experience PRINCETON, N.J., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Kyowa Kirin, Inc., a wholly owned subsidiary of [...]

Pages